ProQR Therapeutics NV
PRQR·Stocks·Pharmaceuticals Major·Netherlands·Nasdaq·USD
Price
$1.70
Today
+0.6%
YTD
-13.1%
About
ProQR Therapeutics is a healthcare firm focussing on the creation of RNA-based therapeutics. It was founded in Leiden, the Netherlands in 2012 and works internationally to combat genetic diseases. It is now traded on the NASDAQ GM under the ticker PRQR. Find out more about PRQR share price news here.
Price chart
Closing price history for PRQR (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-3.44
P/S (TTM)11.74
P/B (TTM)4.21
Market cap$230.07M
Cap tierMicro-cap
Industry avg P/E-43.36
Profitability
Gross margin79.71%
EBIT margin-346.94%
Net margin-658.29%
ROE-81.98%
ROA-37.92%
Earnings & Revenue
Revenue (TTM)$15.53M
Revenue growth (1Y)-23.7%
EPS (TTM)-$0.50
Free cash flow$-59.00M
Total debt$15.77M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.12
Employees186.6
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.